NeoStem Subsidiary Receives Approval to Manufacture Generic Cloxacillin

NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced that its Suzhou Erye Pharmaceutical subsidiary recently received approval from the State Food and Drug Administration in China to manufacture the sterile active pharmaceutical ingredient of the anti-infective cloxacillin sodium.
TradingMarkets